Kobayashi Pharmaceutical

4967.TChemicals

Filed as KOBAYASHI PHARMACEUTICAL CO.,LTD. (2022-08–2026-08)

Key numbers · FY ended 2025-12

Revenue¥165.7bn+0.1% YoY Operating income¥14.9bn-40.0% YoY Net income (owners)¥3.7bn-63.7% YoY Total assets¥275.3bn+3.8% YoY EPS (basic)¥49.19-63.7% YoY

Full financial history and reports →

Stock price4967 · View chart ↗

Open the price chart on TradingView.

Latest filings

Wed, Sep 9 · JST1 filing

16:095% STAKEKobayashi Pharmaceutical · Oasis Management Company Ltd. · 13.37% → 14.41%+1.04pp

Thu, Aug 6 · JST1 filing

15:55MATERIALKobayashi Pharmaceutical · Change in parent company or specified subsidiary

Wed, May 13 · JST1 filing

15:465% STAKEKobayashi Pharmaceutical · Oasis Management Company Ltd. · 13.06% → 13.37%+0.31pp

Tue, Feb 3 · JST1 filing

15:47MATERIALKobayashi Pharmaceutical · Event with a material impact on financial position

Fri, Dec 26 · JST1 filing

16:045% STAKEKobayashi Pharmaceutical · Oasis Management Company Ltd. · 10.10% → 13.06%+2.96pp

All filings →

Major holders (5%+) · 1

Holder	Stake	Change	Filed
Oasis Management Company Ltd.	14.41%	+1.04pp	2026-09-09

Each holder's own ratio from its most recent large-shareholding report.